30 Day Trial

Seikagaku Growth Driven by U.S. Market Gains

Share:

Seikagaku reports FY 3Q19 orthopedic revenue of ¥3,746.2 million (USD $33.8 million), +10.1% vs. 3Q18.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.